Jorge M Aguiar-Geraldo
Overview
Explore the profile of Jorge M Aguiar-Geraldo including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
28
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Scussel R, Fagundes M, Luiz G, Galvani N, Gava F, De Pieri E, et al.
Toxicon
. 2025 Jan;
255:108263.
PMID: 39864753
Tityus serrulatus accident promote vast symptomatology related to toxins of the venom, which leads to a massive release of neurotransmitters, notably dopamine, affecting behavior and neurochemistry. The recommended treatment for...
2.
Aguiar-Geraldo J, Canever L, Marino D, Coan C, Possamai-Della T, Pescador B, et al.
Neurotox Res
. 2025 Jan;
43(1):5.
PMID: 39833594
Given ketamine's conflicting impacts on the central nervous system, investigating its effects within an inflammatory context becomes crucial. This study aimed to assess the impact of varying ketamine doses on...
3.
Rosa J, Sandrini I, Possamai-Della T, Aguiar-Geraldo J, Machado-Laureano M, Zugno A, et al.
Behav Brain Res
. 2024 Apr;
467:115008.
PMID: 38657839
The present study aimed to investigate the effects of paradoxical sleep deprivation (PSD) on behavioral and oxidative stress parameters in the brain and serum of mice submitted to the animal...
4.
Menegas S, Keller G, Possamai-Della T, Aguiar-Geraldo J, Quevedo J, Valvassori S
J Nutr Biochem
. 2023 Sep;
121:109435.
PMID: 37669710
There is a growing body of evidence about the potential of diet and nutrients to improve the population's mental health and the treatment of psychiatric disorders. Some studies have suggested...
5.
Valvassori S, Peper-Nascimento J, Aguiar-Geraldo J, Hilsendeger A, Daminelli T, Juruena M, et al.
J Affect Disord
. 2023 Aug;
340:877-885.
PMID: 37572705
Background: Bipolar disorder (BD) is a chronic, severe, and multifactorial psychiatric disorder. Although biological rhythms alterations, sodium potassium pump (Na, K-ATPase) changes, and oxidative stress appear to play a critical...
6.
Valvassori S, Possamai-Della T, Aguiar-Geraldo J, SantAna R, Dal-Pont G, Pescador B, et al.
Eur J Neurosci
. 2023 Jun;
59(6):1153-1168.
PMID: 37350331
The present study aimed to evaluate if sepsis sensitizes behavioural and biochemical responses induced by m-amphetamine. For this, Wistar rats were submitted to the cecal ligation and puncture. After 30 ...
7.
Possamai-Della T, Cararo J, Aguiar-Geraldo J, Peper-Nascimento J, Zugno A, Fries G, et al.
Mol Neurobiol
. 2023 May;
60(9):5013-5033.
PMID: 37233974
Preclinical genetic studies have related stress early exposures with changes in gene regulatory mechanisms, including epigenetic alterations, such as modifications of DNA methylation, histone deacetylation, and histones acetylation. This study...
8.
Aguiar-Geraldo J, Possamai-Della T, Menegas S, Peper-Nascimento J, Quevedo J, Valvassori S
J Affect Disord
. 2023 May;
334:307-316.
PMID: 37150224
Background: Bipolar disorder (BD) is a complex and severe mental disorder that affects 1-3 % of the world population. Studies have suggested the involvement of oxidative stress in the physiopathology...
9.
Possamai-Della T, Dal-Pont G, Resende W, Aguiar-Geraldo J, Peper-Nascimento J, Quevedo J, et al.
Mol Neurobiol
. 2022 Sep;
59(12):7170-7181.
PMID: 36121567
Introduction: Despite possible risks of mania switching with the long-term use of antidepressants in patients with bipolar disorder (BD), these drugs may help in depressive episodes. Alterations in neurotrophic factor...
10.
Valvassori S, Aguiar-Geraldo J, Possamai-Della T, da-Rosa D, Peper-Nascimento J, Cararo J, et al.
Pharmacol Biochem Behav
. 2022 Jul;
219:173434.
PMID: 35901967
Introduction: A previous study from our Laboratory showed no alteration in inflammatory parameters seven days after ouabain (OUA) administration, a NaKATPase inhibitor, which was previously considered only a mania model....